Lyme disease vaccine - Baxter Healthcare
Alternative Names: mv rOspA LB vaccineLatest Information Update: 15 Sep 2015
At a glance
- Originator State University of New York
- Developer Baxter Healthcare Corporation
- Class Bacterial vaccines; Lyme disease vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Lyme disease
Most Recent Events
- 15 Sep 2015 No recent reports on development identified - Phase-I/II for Lyme disease (Prevention, In volunteers) in Austria and Germany (IM)
- 06 Aug 2014 Lyme disease vaccine - Baxter Healthcare Corporation is available for licensing or divestiture as of 30 July 2014. http://www.baxter.com/
- 01 Feb 2014 Baxter Healthcare Corporation completes a phase I/II trial in Lyme disease (in volunteers, prevention) in Austria and Germany (NCT01504347)